-
August 28, 2021 The Top 10 Psychedelics Stocks’ Financials COMPARED ( Atai, CMPS, MNMD, NUMI, RVV, DMT, TRIP+)What's up psychedelic investors! In this episode, we'll be comparing the top 10 psychedelic stocks'...
-
August 25, 2021 Interview With Chris Kilham, Medicine Hunter Inc.Chris works alongside companies to develop plant-based food and medicinal products, helping turn them into...
-
August 24, 2021 Top 5 Catalysts for Psychedelic Stocks In The Second Half of 2021 (MNMD,CMPS,ATAI,TRYP, CYBN & MORE)What are top 5 catalysts for psychedelic stocks in the second half of 2021? Stay...
-
August 19, 2021 Spiritual Tourism: The Toxic Impact on Indigenous Peoples and Ethical Steps Forward as Psychedelics BoomJessika Lagarde, the co-founder of Women on Psychedelics, explores the negative impacts of psilocybin-fueled spiritual...
-
August 18, 2021 Interview with Evan Levine, PsyBio TherapeuticsIn this episode of the Psychedelic Spotlight podcast, we spotlight Evan Levine, Chairman & CEO...
-
August 17, 2021 MindMed’s Q2 Earnings Call: What does the future hold for MNMD/ MMED?Check out atai Life Sciences' earnings call: https://www.youtube.com/watch?v=lkE3EmU0o_w What's up psychedelic stocks investors?!? Today marked...
-
August 16, 2021 atai Life Sciences Q2 Conference Call and Questions & Answer Period: BIG NEWS for Psychedelic StocksWhat's up psychedelic stocks investors?!? Today marked atai Life Science's (Nasdaq: atai) first-ever conference call,...
-
August 15, 2021 MindMed Financial Results & Business Update Q2 2021 ( Where Does MNMD/MMED Go From Here?)MindMed's Financial Results & Business Update for Q2 2021 are out! In this episode, we'll...
-
August 13, 2021 Interview With Henri Sant-CassiaIn today’s episode of the Psychedelic Spotlight podcast, we spotlight Henri Sant-Cassia, Co-Founding Partner of...
-
August 13, 2021 Mydecine Joins the BIG LEAGUES! MYCO + Johns Hopkins to treat smoking addiction with MAGIC MUSHROOMSMydecine (OTC: MYCOF, NEO: MYCO) is an aspiring psychedelics medicine company that aims to use...
